Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Elevation Oncology, Inc. (the “Company”) for the period ending December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Joseph J. Ferra, Jr., President, Chief Executive Officer and Director of the Company, and Tammy Furlong, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their respective knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated: March 6, 2024	/s/ Joseph J. Ferra, Jr.
	Joseph J. Ferra, Jr.
	President, Chief Executive Officer and Director (Principal Executive Officer)

Dated: March 6, 2024	/s/ Tammy Furlong
	Tammy Furlong
	Chief Financial Officer (Principal Financial and Accounting Officer)